November 2, 2006 - 9:01 AM EST + November 30, 2006 - 9:01 AM EST + December 6, 2006 - 9:00 AM EST + December 7, 2006 - 9:01 AM EST
November 2, 2006 - 9:01 AM EST
NatureWell, Incorporated to Exhibit at Integrative Medicine Conference
SAN DIEGO, Nov. 2 /PRNewswire-FirstCall/ -- NatureWell, Incorporated (the 'Company') (OTC Bulletin Board: NAWL), announced today that it will be an exhibitor at the Annual Conference of the American College for Advancement in Medicine (ACAM) in Palm Springs, CA on November 3rd and 4th, 2006, where it will be marketing its natural migraine medication, MigraSpray(R).
ACAM represents more than 1,000 physicians in 30 countries. In its over 25 year history, ACAM has been dedicated to educating physicians and other health care professionals on the latest findings and emerging procedures in preventive/nutritional medicine. ACAM's goals are to improve skills, knowledge and diagnostic procedures as they relate to complementary and alternative medicine; to support research; and to develop awareness of alternative methods of medical treatment.
James R. Arabia, Chairman and CEO, commented, 'The ACAM conference will provide the Company the ability to reach out to alternative healthcare professionals outside the chiropractic and naturopathic communities who are interested in natural and integrative medicine. We are confident that this will provide a unique opportunity to broaden our marketing reach and further grow our distribution platform.'
About NatureWell, Incorporated:
NatureWell, Incorporated (www.naturewell.com) is an emerging company engaged in the development, marketing and licensing of unique, proprietary healthcare products. The Company currently markets its flagship product MigraSpray (www.migraspray.com), a patented, over-the-counter, homeopathic drug intended to be a comprehensive approach for the treatment and prevention of migraine headaches.
Statements made in this news release should be considered forward-looking and subject to various risks and uncertainties. Such forward-looking statements are based on management's beliefs and assumptions regarding information currently available, and are made pursuant to the 'safe harbor' provisions of the federal securities laws. The Company's actual performance and results could differ materially from those expressed in the forward-looking statements due to certain risks and uncertainties that could materially impact the Company in an adverse fashion and are only predictions of future results, and there can be no assurance that the Company's actual results will not materially differ from those anticipated in these forward-looking statements. Such risks and uncertainties, include, but are not limited to, the Company's ability to secure adequate financing, the Company's ability to ship its products in a timely fashion, volume and timing of orders received, interruption of the manufacturing or distribution of the Company's products or of the supplies or ingredients used to manufacture the Company's products, the effectiveness of the Company's products and consumer perception as to the effectiveness of the products, competitive pricing pressures and the Company's ability to anticipate changes in the market. The Company has no obligation to publicly update or revise any of the forward-looking statements that may be in this news release.
SOURCE NatureWell, Incorporated
Source: PR Newswire (November 2, 2006 - 9:01 AM EST)
News by QuoteMedia
www.quotemedia.com
November 30, 2006 - 9:01 AM EST
NatureWell, Incorporated to Attend Winter Chiropractic Exposition
SAN DIEGO, Nov. 30 /PRNewswire-FirstCall/ -- NatureWell, Incorporated (the 'Company') (OTC Bulletin Board: NAWL), announced today that it will be an exhibitor at the Florida Chiropractic Association (FCA) Winter Convention and Exposition in Fort Lauderdale, Florida on December 1-3, 2006 where it will be marketing MigraSpray, its homeopathic medicine for migraine.
Established in 1931, the Florida Chiropractic Association (www.fcachiro.org) is the largest state chiropractic association in the United States, providing education and representation for chiropractors. The Winter Convention and Exposition is estimated to draw an attendance of nearly 1,000 chiropractors.
Commenting on the conference NatureWell's Chairman and CEO, James R. Arabia, stated, 'The Florida Chiropractic Association National Conference in August proved to be a valuable venue for the Company and we believe that a continued presence at its conferences will increase brand awareness and acceptance of MigraSpray within this large and growing market.'
About NatureWell, Incorporated:
NatureWell, Incorporated (www.naturewell.com) is an emerging company engaged in the development, marketing and licensing of unique, proprietary healthcare products. The Company currently markets its flagship product MigraSpray (www.migraspray.com), a patented, over-the-counter, homeopathic medicine intended to be a comprehensive approach for the treatment and prevention of migraine headaches.
Statements made in this news release should be considered forward-looking and subject to various risks and uncertainties. Such forward-looking statements are based on management's beliefs and assumptions regarding information currently available, and are made pursuant to the 'safe harbor' provisions of the federal securities laws. The Company's actual performance and results could differ materially from those expressed in the forward-looking statements due to certain risks and uncertainties that could materially impact the Company in an adverse fashion and are only predictions of future results, and there can be no assurance that the Company's actual results will not materially differ from those anticipated in these forward-looking statements. Such risks and uncertainties, include, but are not limited to, the Company's ability to secure adequate financing, the Company's ability to ship its products in a timely fashion, volume and timing of orders received, interruption of the manufacturing or distribution of the Company's products or of the supplies or ingredients used to manufacture the Company's products, the effectiveness of the Company's products and consumer perception as to the effectiveness of the products, competitive pricing pressures and the Company's ability to anticipate changes in the market. The Company has no obligation to publicly update or revise any of the forward-looking statements that may be in this news release.
SOURCE NatureWell, Incorporated
Source: PR Newswire (November 30, 2006 - 9:01 AM EST)
News by QuoteMedia
www.quotemedia.com
December 6, 2006 - 9:00 AM EST
NatureWell Enters Into Agreement With 3rd Party Fulfillment Center
SAN DIEGO, Dec. 6 /PRNewswire-FirstCall/ -- NatureWell, Incorporated (OTC Bulletin Board: NAWL), an emerging researcher, developer, and marketer of proprietary, all-natural healthcare products, announced today that it has entered into an agreement with Motivational Fulfillment and Packaging Services ('MFPS'). Under the terms of the agreement, MFPS will provide comprehensive fulfillment administration services, including inventory, order fulfillment, shipping and tracking, and data management and reporting activities. MFPS will initially manage NatureWell's leading product, MigraSpray, a patented, homeopathic solution for the prevention and treatment of migraine headaches, and its distribution to healthcare professionals, independent pharmacies, and direct-to-consumer.
MFPS was founded in 1977 and specializes in fulfillment services including order processing, pick-and-pack, point of purchase packaging and distribution and retail distribution for a wide range of clients. Within its half-million square feet of warehouse space in Chino, California, MFPS has developed specialized computer programs and reporting systems to instantly and accurately manage inventory flow, usage, receiving and damage reporting.
'We are excited to begin working with MFPS,' commented Mr. James R. Arabia, NatureWell, Incorporated's Chairman and Chief Executive Officer. 'We recently initiated and plan to continue a comprehensive marketing awareness program through increased industry presence. We believe that these and additional ongoing efforts will result in increased sales. And through the utilization of MFPS' expertise and state-of-the-art facilities, we will maintain our focus on increasing awareness of MigraSpray, growing our distribution platform, and thereby enhancing our bottom line.'
About NatureWell, Incorporated:
NatureWell, Incorporated (www.naturewell.com) is an emerging company engaged in the development, marketing and licensing of unique, proprietary healthcare products. The Company currently markets its flagship product MigraSpray (www.migraspray.com), a patented, over-the-counter, homeopathic medicine intended to be a comprehensive approach for the treatment and prevention of migraine headaches.
Statements made in this news release should be considered forward-looking and subject to various risks and uncertainties. Such forward-looking statements are based on management's beliefs and assumptions regarding information currently available, and are made pursuant to the 'safe harbor' provisions of the federal securities laws. The Company's actual performance and results could differ materially from those expressed in the forward-looking statements due to certain risks and uncertainties that could materially impact the Company in an adverse fashion and are only predictions of future results, and there can be no assurance that the Company's actual results will not materially differ from those anticipated in these forward-looking statements. Such risks and uncertainties, include, but are not limited to, the Company's ability to secure adequate financing, the Company's ability to ship its products in a timely fashion, volume and timing of orders received, interruption of the manufacturing or distribution of the Company's products or of the supplies or ingredients used to manufacture the Company's products, the effectiveness of the Company's products and consumer perception as to the effectiveness of the products, competitive pricing pressures and the Company's ability to anticipate changes in the market. The Company has no obligation to publicly update or revise any of the forward-looking statements that may be in this news release.
SOURCE NatureWell, Incorporated
Source: PR Newswire (December 6, 2006 - 9:00 AM EST)
News by QuoteMedia
www.quotemedia.com
December 7, 2006 - 9:01 AM EST
NatureWell to Attend the 14th Annual International Congress on Anti-Aging Medicine and Regenerative Biomedical Technologies
SAN DIEGO, Dec. 7 /PRNewswire-FirstCall/ -- NatureWell, Incorporated (OTC Bulletin Board: NAWL), is pleased to announce that it will attend the 14th Annual International Congress on Anti-Aging Medicine and Regenerative Biomedical Technologies (the 'Congress') as an exhibitor, with an expected attendance of more than 6,000 participants, in Las Vegas, Nevada, December 7-10, 2006. NatureWell's attendance and presentation at the Congress will focus on (i) increasing the awareness of MigraSpray, the Company's patented, homeopathic medicine for the prevention and treatment of migraine headaches and (ii) expanding the Company's reseller distribution network to include the medical doctors, osteopathic doctors, and chiropractic doctors attending the Congress.
'We have been really looking forward to the Congress for some time now,' commented Mr. James Arabia, NatureWell, Incorporated's Chairman and Chief Executive Officer. 'The Congress provides us with a unique and significant opportunity to reach thousands of decision-makers, within our targeted medical markets, with respect to the resale distribution of MigraSpray. As a result, there is substantial potential for us to acquire highly qualified sales leads and create relationships within this dynamic market from which we may generate sales and establish accounts. The Company's participation at smaller conferences has already contributed to growth in its distribution platform and we're very excited about the potential of this larger Congress.'
The Congress in Las Vegas, which is sponsored by the American Academy of Anti-Aging Medicine ('A4M'), is the largest and most influential academic and industry event worldwide in the space of preventative medicine and biomedical technologies. Since its founding in 1993, A4M now trains over 30,000 physicians, health practitioners, and scientists annually and influences over 100,000 health professionals worldwide.
About NatureWell, Incorporated:
NatureWell, Incorporated (www.naturewell.com) is an emerging researcher, developer, and marketer of proprietary, all-natural healthcare products. The Company currently markets its flagship product MigraSpray (www.migraspray.com), a patented, over-the-counter, homeopathic medicine intended to be a comprehensive approach for the treatment and prevention of migraine headaches.
Statements made in this news release should be considered forward-looking and subject to various risks and uncertainties. Such forward-looking statements are based on management's beliefs and assumptions regarding information currently available, and are made pursuant to the 'safe harbor' provisions of the federal securities laws. The Company's actual performance and results could differ materially from those expressed in the forward-looking statements due to certain risks and uncertainties that could materially impact the Company in an adverse fashion and are only predictions of future results, and there can be no assurance that the Company's actual results will not materially differ from those anticipated in these forward-looking statements. Such risks and uncertainties, include, but are not limited to, the Company's ability to secure adequate financing, the Company's ability to ship its products in a timely fashion, volume and timing of orders received, interruption of the manufacturing or distribution of the Company's products or of the supplies or ingredients used to manufacture the Company's products, the effectiveness of the Company's products and consumer perception as to the effectiveness of the products, competitive pricing pressures and the Company's ability to anticipate changes in the market. The Company has no obligation to publicly update or revise any of the forward-looking statements that may be in this news release.
SOURCE NatureWell, Incorporated
Source: PR Newswire (December 7, 2006 - 9:01 AM EST)
News by QuoteMedia
www.quotemedia.com
AI
